A 32-year-old female was admitted for evaluation of multiple infiltrates on a chest radiograph. A diagnosis of multicentric Castleman's disease was made on the basis of typical clinical manifestations. Transbronchial lung biopsy (TBLB) revealed histological findings reported in lymphocytic interstitial pneumonia. Both the polymerase chain reaction and in situ hybridization with a probe specific for Kaposi's sarcoma-associated herpesvirus (KSHV)sequences demonstrated the presence of KSHVin the TBLBsample. (Internal Medicine 38: 279-282, 1999) 
Introduction Multicentric
Castleman's disease (MCD) is a rare lymphoproliferative disorder characterized by systemic lymphadenopathy, multiple organ involvement, polyclonal hypergammaglobulinemia, and other nonspecific clinical manifestations such as fever, anemia, an elevated erythrocyte sedimentation rate, and an increased serum interleukin-6 (IL-6) level (1) . Epidemiologic studies suggest a close association between MCDand Kaposi's sarcoma, which occurs during the clinical course ofMCDin 13%-75% of cases (1, 2) . This epidemiologic finding is further supported by the recent identification of a new herpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8), in samples obtained from both Kaposi's sarcoma and from MCD (2) (3) (4) .
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Although little is known with regard to the pulmonary lesions of MCD, a case of MCD with lymphocytic interstitial pneumonia (LIP) has been documented (5). Here, we report a case of MCDwith lymphoproliferative lesions in the lung in which KSHV infection was demonstrated.
Case Report
A 32-year-old HIV-negative Japanese female was admitted to our hospital for evaluation of abnormalshadowson a routine chest radiograph. She was asymptomatic, and physical examination showedno abnormalities except for left supraclavicular and bilateral axillar lymphadenopathy. Laboratory data disclosed normocytic anemia of 9.3 g/dl hemoglobin, an elevated erythrocyte sedimentation rate of 1 28 mm/h, hypoalbuminemia of 2.7 g/dl, and a polyclonal hypergammaglobulinemia of 5.9 g/dl, mostly composed of increases in immunoglobulin G (IgG). Serum IL-6 was increased to 13.1 pg/dl (normal range: <4 pg/dl). Liver and renal function tests were normal. A plain film and computed tomography of the chest ( Fig. 1) showed multiple hazy infiltrates in both lung fields, with interseptal thickening and mediastinal lymphadenopathy. Pulmonary function studies were normal, and bacterial cultures of sputum and sputum cytology were negative.
Broncho-fiberscopy with bronchoalveolar lavage demonstrated a mild lymphocytosis of 9.1%, with the B-cell (CD20+) fraction increased to 18.2%, Transbronchial lung biopsy (TBLB) (Fig. 2) revealed infiltration of lymphocytes, macrophages, and fewer plasma cells, with formation of lymphoid follicles in the alveolar and peribronchiolar interstitium, which is similar to the histological findings reported in LIP (6) . Immunohistochemical staining of the TBLBspecimen was positive for both k and X immunoglobulin, indicating polyclonal proliferation of lymphocytes and plasma cells in the lung (Fig. 2B, C) . These histologic findings together with the presence of clinical features such as multicentric lymphadenopathy, polyclonal hypergammaglobulinemia,an elevated erythrocyte sedimen- and X, (C) gammaglobulins. tation rate, and an increased serum IL-6 level were the basis for making the diagnosis of MCD. To investigate the etiology, the TBLBspecimen was analyzed for KSHV. Polymerase chain reaction (PCR) was performed as described previously (7) to detect the KS330233 sequence, which represents a 233-bp fragment of the KS330 Bam region of KSHV(3). Briefly, 100 ng of genomic DNAwas extracted from the sample and a total of 35 cycles of PCRamplification was performed using the following primers: forward primer, 5 '-AGCCGAAAGGATTCCACCAT-3' ; reverse primer, 5'-TCCGTGTTGTCTACGTCCAG-3' (3 , 7). The PCR product was electrophoresed on a 1%agarose gel containing ethidium bromide and photographed. As shown in Fig. 3 , the KS330233sequence was detected in the lung specimen obtained from this patient, but not in the lung specimen obtained from a control subject having an irrelevant lung disease. Wealso performed dot blotting of the PCRamplification product with a 32p end-labeled probe internal to the KS330233 sequence 5'-TGCAGCAGCTGTTGGTGTACCACA-3' as described (8) and found that the PCRproduct specifically hybridized with the internal probe (data not shown).
In situ hybridization was performed as another confirmatory technique to document the specificity of the KSHVinfection of KSHVInfection in the Lung 
. In situ hybridization with the KSHVprobe demonstrated nuclear and cytoplasmic staining (7) of some cells infiltrating the pulmonary interstitium (Fig. 4) . Either omission of the KSHV probe or replacement of the probe with an irrelevant oligonucleotide probe (rat IL-6 probe) resulted in negative staining.
These KSHV-positive cells, although not identified, appear to represent macrophages due to their relatively large size. Immunohistochemical and ultrastructural studies to identify these cells could not be performed.
Discussi on
In the present case, a diagnosis of MCDwas made primarily on the basis of typical clinical manifestations including multifocal lymphadenopathy, polyclonal hypergammaglobulinemia with hypoalbuminemia,an elevated erythrocyte sedimentation rate, and an increased IL-6 level. Thus, it should be noted that the diagnosis of MCDmay not be definite because lymph node biopsy, which is essential for histological diagnosis of MCD,could not be performed. MCDis a rare lymphoproliferative disorder that involves multiple organs, in addition to lymph nodes (1), but little attention has been paid to involvement of the lung. We have described a case having typical clinical manifestations of MCD and involving the lung which showed histological pictures similar to that of LIP. LIP can occur idiopathically, in association with Sjoren's syndrome and other autoimmunediseases, and in people infected with human immunodeficiency virus (HIV) (6) . The present case suggests that pulmonary lesions resembling LIP may also occur as a manifestation ofMCD.Although little is known with regard to pulmonary lesions of MCD,a recent report has also described a case of MCDwith pulmonary lesions resembling LIP(5). Wealso detected evidence of KSHVinfection in the lung lesion. KSHV,a gammaherpes virus related to Epstein-Barr virus, was first identified in acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (3), but was later detected in lymph nodes of MCDas well (2). To our knowledge, our report is the first to document detection of KSHVin an extranodal organ in MCD. It might be suggested that leukocytes circulating in the pulmonary vasculature were the source of the PCRproduct we detected. However, in situ hybridization demonstrated that KSHV-positive cells were located in the extravascular space of the pulmonary interstitium. Although we detected evidence of KSHVinfection in the lung, it remains unclear whether KSHV is responsible for the pulmonary lesion found in this case. Wecannot exclude the possibility that KSHVinfection is incidental and irrelevant to the pathogenesis of the pulmonary lesion. Nevertheless, recent evidence suggests that KSHVmayplay a role in the pathogenesis of lymphoproliferative disorders. KSHVsequences share homologies with manycellular genes, including host genes known to function in cell growth (cyclin D), apoptosis (bcl-2), cell-cell interaction (OX-2), immunoregulation, and cytokine signaling (IL-6, CC chemokines, CXCchemokine receptors) (10) . It therefore seems reasonable to suppose that cytokines, cytokine receptors, and growth regulatory proteins encoded by these viral genes support the proliferation and activation of lymphoid cells in KSHV-infected tissues. In fact, many of these viral genes have been shownto encode proteins that preserve the functions predicted by their homologies (10) . A good example of this is viral IL-6, a pleiotropic cytokine for lymphoid cells. There is much evidence to show that viral IL-6 plays a causative role in MCD (1, 10) . To date, however, there has not been enough evidence to show that viral IL-6 also plays a role in lymphoproliferative lung diseases such as LIP. There is also a lack of evidence that other KSHV-associated genes, such as viral bcl-2, CXCchemokine receptor, and cyclin D, are present in the lung in lymphoproliferative diseases. Nevertheless, our findings suggest that viruses such as KSHV that have genes homologousto host genes mayplay a causative role in at least some types of pulmonary lymphoproliferative disorders. KSHV infection of the lung mayallow the virus to express its genes that support lymphoid and inflammatory reactions in the lung, such as the genes encoding cytokines and cell growth. An epidemiologic study using serologic tests for KSHVinfection has shown that at least l%-2% of the general population is seropositive for KSHV, indicating past exposure and ongoing latency in at least some host cells (10) . Our findings mayprovide a clue to the pathogenesis of lymphoproliferative lung diseases, whose cause needs to be clarified. Given the highly unusual biology of KSHV,it is important to search for further evidence of pulmonary infection with KSHV
